CEO median pay rose 9.5% in 2024, less than the prior year but more than inflation and average worker pay. Shareholders did ...

Aquaron Acquisition Corp. ("Aquaron” or the "Company”) (OTCMKTS: AQUC), a publicly traded special purpose acquisition company, today announced that its Annual Meeting of Stockholders (the "Annual ...

Enrollment complete in the 12 mg dose cohort (n=16) of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD); initiated the 20 mg dose cohort ― ― On track to provide clinical data from ...